Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Related structures:
AlphaFold database: A4I930
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 221 | 227 | PF00089 | 0.576 |
CLV_NRD_NRD_1 | 272 | 274 | PF00675 | 0.598 |
CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.465 |
CLV_PCSK_KEX2_1 | 274 | 276 | PF00082 | 0.664 |
CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.553 |
CLV_PCSK_PC1ET2_1 | 274 | 276 | PF00082 | 0.664 |
CLV_PCSK_SKI1_1 | 219 | 223 | PF00082 | 0.572 |
CLV_PCSK_SKI1_1 | 22 | 26 | PF00082 | 0.498 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.397 |
CLV_PCSK_SKI1_1 | 40 | 44 | PF00082 | 0.525 |
DEG_APCC_DBOX_1 | 124 | 132 | PF00400 | 0.573 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.519 |
DEG_SCF_FBW7_1 | 4 | 11 | PF00400 | 0.527 |
DEG_SPOP_SBC_1 | 309 | 313 | PF00917 | 0.590 |
DOC_CYCLIN_RxL_1 | 104 | 115 | PF00134 | 0.469 |
DOC_CYCLIN_RxL_1 | 19 | 28 | PF00134 | 0.474 |
DOC_MAPK_gen_1 | 29 | 35 | PF00069 | 0.437 |
DOC_PP1_RVXF_1 | 105 | 112 | PF00149 | 0.463 |
DOC_PP1_RVXF_1 | 32 | 39 | PF00149 | 0.433 |
DOC_PP2B_LxvP_1 | 323 | 326 | PF13499 | 0.565 |
DOC_USP7_MATH_1 | 172 | 176 | PF00917 | 0.640 |
DOC_WW_Pin1_4 | 4 | 9 | PF00397 | 0.521 |
DOC_WW_Pin1_4 | 59 | 64 | PF00397 | 0.741 |
LIG_14-3-3_CanoR_1 | 120 | 124 | PF00244 | 0.521 |
LIG_14-3-3_CanoR_1 | 184 | 192 | PF00244 | 0.478 |
LIG_14-3-3_CanoR_1 | 34 | 39 | PF00244 | 0.496 |
LIG_Actin_WH2_2 | 135 | 152 | PF00022 | 0.491 |
LIG_Actin_WH2_2 | 71 | 87 | PF00022 | 0.475 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.528 |
LIG_FHA_1 | 116 | 122 | PF00498 | 0.485 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.418 |
LIG_FHA_1 | 184 | 190 | PF00498 | 0.511 |
LIG_FHA_1 | 199 | 205 | PF00498 | 0.376 |
LIG_FHA_1 | 254 | 260 | PF00498 | 0.681 |
LIG_FHA_1 | 280 | 286 | PF00498 | 0.620 |
LIG_FHA_1 | 5 | 11 | PF00498 | 0.524 |
LIG_FHA_1 | 69 | 75 | PF00498 | 0.478 |
LIG_FHA_2 | 96 | 102 | PF00498 | 0.523 |
LIG_LIR_Gen_1 | 179 | 189 | PF02991 | 0.532 |
LIG_LIR_Nem_3 | 179 | 185 | PF02991 | 0.551 |
LIG_LIR_Nem_3 | 288 | 292 | PF02991 | 0.565 |
LIG_SH2_CRK | 182 | 186 | PF00017 | 0.503 |
LIG_SH2_STAP1 | 229 | 233 | PF00017 | 0.533 |
LIG_SH2_STAP1 | 56 | 60 | PF00017 | 0.601 |
LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.641 |
LIG_SH2_STAT5 | 261 | 264 | PF00017 | 0.610 |
LIG_SH2_STAT5 | 268 | 271 | PF00017 | 0.587 |
LIG_SH3_3 | 137 | 143 | PF00018 | 0.533 |
LIG_SH3_3 | 20 | 26 | PF00018 | 0.406 |
LIG_SH3_3 | 222 | 228 | PF00018 | 0.571 |
LIG_SH3_3 | 230 | 236 | PF00018 | 0.463 |
LIG_SUMO_SIM_anti_2 | 136 | 141 | PF11976 | 0.540 |
LIG_TRAF2_1 | 47 | 50 | PF00917 | 0.567 |
LIG_WRC_WIRS_1 | 35 | 40 | PF05994 | 0.449 |
MOD_CDC14_SPxK_1 | 62 | 65 | PF00782 | 0.749 |
MOD_CDK_SPxK_1 | 59 | 65 | PF00069 | 0.749 |
MOD_CK1_1 | 198 | 204 | PF00069 | 0.517 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.524 |
MOD_CK1_1 | 252 | 258 | PF00069 | 0.628 |
MOD_CK1_1 | 313 | 319 | PF00069 | 0.526 |
MOD_CK1_1 | 41 | 47 | PF00069 | 0.647 |
MOD_CK1_1 | 95 | 101 | PF00069 | 0.478 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.555 |
MOD_CK2_1 | 95 | 101 | PF00069 | 0.514 |
MOD_Cter_Amidation | 271 | 274 | PF01082 | 0.658 |
MOD_GlcNHglycan | 198 | 201 | PF01048 | 0.509 |
MOD_GlcNHglycan | 256 | 259 | PF01048 | 0.597 |
MOD_GlcNHglycan | 323 | 326 | PF01048 | 0.582 |
MOD_GlcNHglycan | 94 | 97 | PF01048 | 0.596 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.487 |
MOD_GSK3_1 | 172 | 179 | PF00069 | 0.693 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.553 |
MOD_GSK3_1 | 249 | 256 | PF00069 | 0.629 |
MOD_GSK3_1 | 275 | 282 | PF00069 | 0.652 |
MOD_GSK3_1 | 309 | 316 | PF00069 | 0.685 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.497 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.527 |
MOD_LATS_1 | 160 | 166 | PF00433 | 0.651 |
MOD_NEK2_1 | 196 | 201 | PF00069 | 0.505 |
MOD_NEK2_1 | 319 | 324 | PF00069 | 0.518 |
MOD_NEK2_1 | 38 | 43 | PF00069 | 0.573 |
MOD_NEK2_2 | 243 | 248 | PF00069 | 0.539 |
MOD_PKA_2 | 119 | 125 | PF00069 | 0.517 |
MOD_PKA_2 | 183 | 189 | PF00069 | 0.484 |
MOD_PKB_1 | 273 | 281 | PF00069 | 0.593 |
MOD_Plk_1 | 217 | 223 | PF00069 | 0.554 |
MOD_Plk_4 | 217 | 223 | PF00069 | 0.705 |
MOD_Plk_4 | 243 | 249 | PF00069 | 0.535 |
MOD_Plk_4 | 314 | 320 | PF00069 | 0.513 |
MOD_Plk_4 | 38 | 44 | PF00069 | 0.481 |
MOD_ProDKin_1 | 4 | 10 | PF00069 | 0.527 |
MOD_ProDKin_1 | 59 | 65 | PF00069 | 0.739 |
MOD_SUMO_rev_2 | 110 | 118 | PF00179 | 0.312 |
MOD_SUMO_rev_2 | 91 | 95 | PF00179 | 0.520 |
TRG_DiLeu_BaLyEn_6 | 144 | 149 | PF01217 | 0.503 |
TRG_DiLeu_BaLyEn_6 | 234 | 239 | PF01217 | 0.662 |
TRG_DiLeu_BaLyEn_6 | 31 | 36 | PF01217 | 0.420 |
TRG_ENDOCYTIC_2 | 182 | 185 | PF00928 | 0.538 |
TRG_ER_diArg_1 | 104 | 107 | PF00400 | 0.481 |
TRG_ER_diArg_1 | 20 | 23 | PF00400 | 0.531 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IHI6 | Leishmania donovani | 100% | 100% |
E9B3Z5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q4Q429 | Leishmania major | 94% | 100% |